Zio XT ECG Monitoring System vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by RhythmScience

AI Verdict

Tool A, Zio XT, offers a proprietary wearable ECG biosensor and AI analysis for continuous cardiac monitoring and arrhythmia detection. In contrast, Tool B, Rhythm360, is a vendor-neutral platform designed to aggregate and analyze data from various cardiac monitoring devices, focusing on workflow automation, alert triage, and comprehensive cardiac condition management. While both leverage AI for cardiac care and remote monitoring, Tool A provides a specific monitoring solution, whereas Tool B offers an overarching data management and insights platform.

Choose Zio XT ECG Monitoring System if…

Choose Zio XT if your primary need is a highly compliant, patient-friendly solution for extended, continuous ambulatory ECG monitoring to detect arrhythmias. Its wearable, water-resistant biosensor and lack of external wires make it ideal for patients requiring up to 14 days of comfortable, uninterrupted monitoring in their daily lives.

View Zio XT ECG Monitoring System →

Choose Rhythm360 if…

Choose Rhythm360 if your practice manages a diverse patient population with various cardiac devices and requires a unified platform for comprehensive data aggregation and workflow optimization. This tool excels at reducing alert fatigue through AI-driven triage, streamlining EHR integration, and automating billing processes across multiple device types.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio XT ECG Monitoring System Rhythm360
Pricing Contact for pricing Flexible pricing model that scales with clinic size and platform usage.
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware required. Cloud-based SaaS platform
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Zio XT excels in patient usability with its comfortable, wire-free, and water-resistant wearable biosensor, leading to high patient compliance (up to 99%). While Rhythm360 offers strong clinician-focused usability features like alert triage and EHR integration, Zio XT's direct impact on patient comfort and ease of use for continuous monitoring gives it an edge in overall system usability from the primary user's perspective.

Clinical Value

Rhythm360

Rhythm360 offers broader clinical value by unifying data from various cardiac devices and providing actionable insights for multiple conditions, including hypertension, heart failure, and rhythm management. Its predictive algorithms for heart failure management and ability to reduce alert fatigue demonstrate a more comprehensive approach to cardiac care beyond just arrhythmia detection, which is Zio XT's primary focus.

Pricing & Value

Zio XT ECG Monitoring System

Zio XT provides more transparent pricing details, with specific costs available for the UK (u00a3310 per patient) and proposed Medicare rates in the US ($229-$260.35). In contrast, Rhythm360 describes a flexible, SaaS-based model that scales with usage, but also notes 'premium pricing' as a potential con, making its value proposition less clear without direct contact.

Enterprise Readiness

Rhythm360

Rhythm360 demonstrates superior enterprise readiness through its extensive bi-directional EHR integrations (Epic, Cerner, Athenahealth, etc.), vendor-neutral data aggregation from all major OEMs, and automated CPT code documentation and billing. These features are crucial for seamless integration into large healthcare systems and streamlining administrative workflows.

Innovation

Rhythm360

While Zio XT features an innovative wearable biosensor with FDA-cleared AI for arrhythmia detection, Rhythm360 showcases broader innovation in its AI-powered integrated platform. Its ability to unify data from diverse devices, apply AI for multiple conditions (hypertension, heart failure, rhythm management), and perform advanced AI Data Normalization, including PDF parsing via computer vision, represents a more complex and comprehensive technological advancement.

Support & Docs

Rhythm360

Rhythm360 explicitly highlights an 'Optional 24/7/365 oversight by certified cardiac technicians (CCTs)' as a key feature, indicating a robust and continuous support model. While Zio XT offers general patient and professional resources, the direct mention of round-the-clock expert oversight for Rhythm360 suggests a higher level of dedicated support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio XT ECG Monitoring System Rhythm360
Name Zio XT ECG Monitoring System Rhythm360
Company iRhythm Technologies RhythmScience
Primary Function Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for arrhythmia detection and diagnosis. AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Key Monitoring/Data Source Wearable single-lead ECG biosensor (Zio biosensor) for continuous ambulatory cardiac monitoring for up to 14 days. Vendor-neutral data aggregation from all major OEM cardiac devices (Medtronic, Boston Scientific, Abbott, Biotronik).
AI Capabilities Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis. AI-driven alert triage (80% faster response times, reduces alert fatigue), AI Data Normalization (API, HL7, XML, PDF parsing via computer vision), predictive algorithms for Heart Failure Management.
EHR Integration Not specified Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity).

Videos

Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Zio XT is a wearable, single-lead ECG biosensor system designed for up to 14 days of continuous ambulatory cardiac monitoring, primarily for arrhythmia detection and diagnosis. Rhythm360 is an integrated AI-powered platform that unifies cardiac monitoring data from various devices to provide actionable insights for hypertension, heart failure, and rhythm management.
Zio XT utilizes its proprietary Zio biosensor for data collection and analysis, and its software platform (ZEUS) is designed for this specific data. In contrast, Rhythm360 is vendor-neutral, aggregating data from all major OEM cardiac devices, including those from Medtronic, Boston Scientific, Abbott, and Biotronik.
Zio XT uses an FDA-cleared deep-learned AI algorithm for ECG data analysis and accurate arrhythmia detection, which is then reviewed by experts. Rhythm360 employs AI for alert triage to reduce alert fatigue, normalize diverse data, and provide predictive algorithms for heart failure management.
Zio XT's service includes the biosensor, analysis, and data reporting, with proposed Medicare rates for its CPT codes 93247 and 93243. Rhythm360 offers automated CPT code documentation and billing for various codes, such as 93298, 93299, 99454, 99453, and 99457, and can help launch and scale remote patient monitoring programs.
Zio XT's data is managed through its cloud-based ZEUS software platform for storage, analysis, and reporting, with HL7-based EHR integration for data exchange. Rhythm360 offers bi-directional EHR integration with major systems like Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, and GE Centricity.
Zio XT is designed for continuous ambulatory cardiac monitoring to detect and diagnose cardiac arrhythmias, suitable for Cardiology, Emergency Medicine, and Internal Medicine. Rhythm360 provides actionable insights for a broader range of conditions, including hypertension, heart failure, and rhythm management, with a focus on cardiology.
Zio XT's ECG recordings are analyzed by its algorithm and then overseen by accredited cardiac physiologists, with a technical report sent to the prescribing healthcare professional. Rhythm360 offers optional 24/7/365 oversight by certified cardiac technicians (CCTs) to support clinical decision-making.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.